Drugs acting on the cholinergic system can improve or worsen cognitive abilities, and their effects are particularly pronounced in frail elderly individuals and patients with Alzheimer disease.

the authors suggest that cholinergic modulating drugs might improve ataxia and possibly other symptoms in patients with MSA-C or SCA3.